Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Neurosurgery

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3171/2012.5.JNS111929PMID 22702482PMCID PMC6098938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.

  2012cited by this paper
• Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

  2011cited by this paper
• Melanoma brain metastases: is it time to reassess the bias?

  2011cited by this paper
• Determinants of survival in patients with brain metastases from cutaneous melanoma

  2010cited by this paper
• Improved survival with ipilimumab in patients with metastatic melanoma.

  2010cited by this paper
• Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

  2009cited by this paper
• Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.

  2009cited by this paper
• Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

  2007cited by this paper
• Cranial irradiation after surgical excision of brain metastases in melanoma patients

  2006cited by this paper
• Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.

  2000cited by this paper
• Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

  1998cited by this paper
• Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.

  1996cited by this paper
• Central nervous system involvement in malignant melanoma.

  1988cited by this paper
• Central nervous system lnvolvement in malignant melanoma

  1988cited by this paper
• Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves.

  1985cited by this paper

• The clinical benefit of adding radiotherapy to ipilimumab in patients with melanoma brain metastasis: a systematic review and meta-analysis

  2025cites this paper
• Recent Advances in Molecular Research and Treatment for Melanoma in Asian Populations

  2025cites this paper
• Survival benefits and toxicity effects of radiotherapy and immunotherapy treatments in melanoma patients with brain metastases: A meta-analysis study

  2025cites this paper
• CTLA-4 and PD-1 combined blockade therapy for malignant melanoma brain metastases: mechanisms, challenges, and prospects

  2025cites this paper
• Immune checkpoint inhibitor (ICI) therapy in central nervous system cancers: State-of-the-art and future outlook.

  2025cites this paper
• Evolutionary Trend Analysis of Research on Immunotherapy for Brain Metastasis Based on Machine-Learning Scientometrics

  2024cites this paper
• Melanoma Brain Metastasis: Biology and Therapeutic Advances.

  2024cites this paper
• The role of radiotherapy in immunotherapy strategies in the central nervous system.

  2024cites this paper
• Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era

  2024cites this paper
• Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era

  2024cites this paper
• Immunotherapeutic Strategies for Intra-cranial Metastatic Melanoma - a Meta-analysis and Systematic Review

  2024cites this paper
• Biological Insights and Radiation–Immuno–Oncology Developments in Primary and Secondary Brain Tumors

  2024cites this paper
• Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure

  2023cites this paper
• Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvement

  2023cites this paper
• Synergistic effects of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with lung cancer and brain metastases: a propensity score-matched analysis.

  2023cites this paper
• Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity

  2023cites this paper
• Immunotherapy plus stereotactic body radiation therapy or whole-brain radiation therapy in brain metastases.

  2023cites this paper
• Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis

  2023cites this paper
• Long duration of immunotherapy before radiosurgery might improve intracranial control of melanoma brain metastases.

  2023cites this paper
• Radiotherapy and blockade of immune checkpoints in treatment of cancer patients

  2023cites this paper
• Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases

  2023cites this paper
• The Safety and Efficacy of Concurrent Immune Checkpoint Blockade and Stereotactic Radiosurgery Therapy with Practitioner and Researcher Recommendations.

  2023cites this paper
• Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era

  2023cites this paper
• Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis

  2023cites this paper
• Role of radiotherapy in the management of brain oligometastases.

  2023cites this paper
• Current landscape and challenges ahead of immuno-molecular mechanism and immunotherapy strategy of brain metastases

  2023influential citation
• Efficacy and safety of combined immunotherapy and stereotactic radiosurgery in NSCLCBM patients and a novel prognostic nomogram: A real-world study

  2023cites this paper
• Effect of Immunotherapy and Stereotactic Body Radiation Therapy Sequencing on Local Control and Survival in Patients With Spine Metastases

  2023cites this paper
• Immunotherapy as a Turning Point in the Treatment of Melanoma Brain Metastases

  2023cites this paper
• Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

  2022influential citation
• Radiation Therapy for Melanoma Brain Metastases: A Systematic Review

  2022cites this paper
• Integrating stereotactic radiotherapy and systemic therapies

  2022cites this paper
• Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis.

  2022cites this paper
• PD-1/PD-L1 Blockade in Cancer Immunotherapy: Clinical Benefits, Limitations and Beyond

  2022cites this paper
• State of the Art in Combination Immuno/Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis

  2022cites this paper
• Brain metastases, patterns of intracranial progression, and the clinical value of upfront cranial radiotherapy in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

  2022cites this paper
• Intracranial Metastatic Disease: Present Challenges, Future Opportunities

  2022cites this paper
• Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors

  2022cites this paper
• Stereotactic radiosurgery with immune checkpoint inhibitors for brain metastases: a meta-analysis study

  2022cites this paper
• Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy

  2022cites this paper
• The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021

  2022cites this paper
• Stereotactic radiosurgery combined with immune checkpoint inhibitors for brain metastasis: A systematic review and meta-analysis.

  2022cites this paper
• Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents

  2022cites this paper
• Emergent immunotherapy approaches for brain metastases

  2021cites this paper
• The microenvironment of brain metastases from solid tumors

  2021cites this paper
• Brain Metastases: An Update on Multi-disciplinary Approach of Clinical Management.

  2021cites this paper
• ROLE OF STEREOTACTIC RADIOSURGERY FOR THE TREATMENT OF BRAIN METASTASIS IN THE ERA OF IMMUNOTHERAPY: A SYSTEMATIC REVIEW ON CURRENT EVIDENCES AND PREDICTING FACTORS.

  2021cites this paper
• Polymeric Nanosystems for Immunogenic Cell Death-Based Cancer Immunotherapy.

  2021cites this paper
• Single- and hypofractionated stereotactic radiosurgery for large (> 2 cm) brain metastases: a systematic review

  2021cites this paper
• Emerging principles of brain immunology and immune checkpoint blockade in brain metastases.

  2021cites this paper
• Nonsurgical Management of Melanoma Brain Metastasis: Current Therapeutics, Challenges, and Strategies for Progress.

  2021cites this paper
• Narrative review of immune checkpoint inhibitors and radiation therapy for brain metastases

  2021cites this paper
• Ipilimumab and Stereotactic Radiosurgery with CyberKnife® System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience

  2021cites this paper
• Stereotactic Radiosurgery (SRS) experience on brain metastases: A 3-year retrospective study at King Abdulaziz University Hospital

  2021influential citation
• Long-term Overall Survival and Predictors in Anti–PD-1-naive Melanoma Patients With Brain Metastases Treated With Immune Checkpoint Inhibitors in the Real-world Setting: A Multicohort Study

  2021cites this paper
• Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors.

  2021cites this paper
• Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safety

  2021cites this paper
• Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies

  2021cites this paper
• Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments

  2021cites this paper
• Efficacy of BRAF Inhibitors in Combination With Stereotactic Radiosurgery for the Treatment of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis

  2021cites this paper
• Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases

  2021cites this paper
• The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type

  2021cites this paper
• Efficacy and safety of combined brain radiotherapy and immunotherapy in melanoma patients with brain metastases: A systematic review and meta-analysis.

  2021cites this paper
• A Contemporary Report of Clinical Outcomes in Patients with Melanoma Brain Metastases

  2021cites this paper
• Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review

  2021influential citation
• Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors

  2020cites this paper
• Impact of Immunotherapy on the Survival of Patients With Cancer and Brain Metastases

  2020cites this paper
• Efficacy of radiotherapy vs. The combination of radio- and immunotherapy: a systematic review and meta-analysis

  2020cites this paper
• Intracranial radiotherapy with or without immune checkpoint inhibition for brain metastases: a systematic review and meta-analysis

  2020cites this paper
• Association of Immunotherapy With Survival Among Patients With Brain Metastases Whose Cancer Was Managed With Definitive Surgery of the Primary Tumor

  2020cites this paper
• Management of brain metastases according to molecular subtypes

  2020cites this paper
• Immune Therapy for Central Nervous System Metastasis.

  2020cites this paper
• Enhancing the efficacy of immunotherapy using radiotherapy

  2020cites this paper
• The Association of Treatment Facility Type With the Survival of Brain Metastases Patients Regardless of the Primary Site Cancer

  2020cites this paper
• Current Multimodality Treatments against Brain Metastases from Renal Cell Carcinoma

  2020cites this paper
• Quantification of Scheduling Impact on Safety and Efficacy Outcomes of Brain Metastasis Radio- and Immuno-Therapies: A Systematic Review and Meta-Analysis

  2020cites this paper
• Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy.

  2020cites this paper
• Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG

  2020cites this paper
• Role of Precision Medicine in Patients with CNS Metastasis

  2020cites this paper
• Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy—A retrospective cohort study

  2020cites this paper
• Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons.

  2020cites this paper
• Brain metastasis formation and irradiation by stereotactic radiation therapy combined with immunotherapy: A systematic review.

  2020cites this paper
• Immunotherapy Bridge 2019 and Melanoma Bridge 2019: meeting abstracts

  2020cites this paper
• Current approaches to the management of brain metastases

  2020cites this paper
• Hypofractionated radiation therapy with versus without immune checkpoint inhibitors in patients with brain metastases: A meta-analysis.

  2020cites this paper
• Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors

  2020cites this paper
• The Combination of Radiotherapy with Pembrolizumab in the Treatment of Metastatic Melanoma Patients: a Systematic Review

  2020cites this paper
• Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors

  2020cites this paper
• Synergy of Immunotherapy and Radiosurgery

  2020cites this paper
• Radiation Necrosis Following the Radiosurgical Treatment of Brain Metastases

  2020cites this paper
• Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study.

  2020cites this paper
• Current Treatment of Melanoma Brain Metastasis

  2020cites this paper
• Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy

  2020cites this paper
• Combination of Stereotactic Radiosurgery with Immunotherapy: Is It a New Treatment Option for Brain Metastases?

  2020cites this paper
• Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery

  2020cites this paper
• Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study

  2020cites this paper
• Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis

  2020cites this paper
• Optimal treatment strategy for metastatic melanoma patients harboring BRAF-V600 mutations

  2020cites this paper
• Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers

  2019cites this paper
• Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases.

  2019cites this paper